{"product_id":"9789041142788","title":"Patent Practice in Japan and Europeiber Amicorum for Guntram Rahn","description":"More than 60 authors – supreme and high court judges, law professors, legal specialists in corporate and private practice – from Europe, East Asia, and the United States contribute original essays to this excellent compilation of the current issues regarding the laws and practices in intellectual property in Europe and Japan. \u003cbr\u003e\u003cbr\u003eThe articles cover a broad spectrum of subjects, including the procedural implications of litigation, international jurisdiction, doctrines of exhaustion, utility model systems and practice, and employed inventor’s compensation, as well as the special aspects of pharmaceutical patenting such as obtaining supplementary protection certificates. Many of the articles also include a comparative analysis of the laws and practices in both geographical regions or deal with the same legal issues but in different jurisdictions, for instance: \u003cbr\u003e\u003cbr\u003ethe reform of the Japanese judicial system to establish an IP-based nation; \u003cbr\u003ethe role of patent firms in the economic development of Japan; \u003cbr\u003edisclosure requirements in Japan: a judge's view; \u003cbr\u003eI.P. High Court decisions on inventive step; \u003cbr\u003einternational jurisdiction in Japan, Europe and the United States; \u003cbr\u003epatent infringement by multiple parties in Japan; \u003cbr\u003epatent exhaustion in Japan; \u003cbr\u003ecorporate remuneration systems for employees' inventions in Japan and Germany; \u003cbr\u003ethe present and future of Japan's utility model system; \u003cbr\u003enotable differences between Korean and German patent infringement and invalidation practices; \u003cbr\u003efifteen years of the Eurasian Patent System; \u003cbr\u003ethe future European and EU Patents Court; \u003cbr\u003eopposition proceedings at the EPO: tips for success; \u003cbr\u003ethe interaction between infringement and invalidity decisions in German patent disputes; \u003cbr\u003eprotection of confidential information in patent litigation in the UK and Germany; \u003cbr\u003einterpretation and determination of the scope of patents by the French Courts; \u003cbr\u003eprovocative thoughts on the patenting of new pharmaceuticals; \u003cbr\u003eObama Care: implications for research pharmaceutical companies; \u003cbr\u003eand many others.","brand":"Wolters Kluwer Law \u0026 Business","offers":[{"title":"Default Title","offer_id":47185084678384,"sku":"9789041142788","price":238.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9789041142788_p0.jpg?v=1763670250","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9789041142788","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}